European Union 
Co-financing from the state budget 29.06.2022
PRICE INQUIRY No. 6 - being conducted as a market assessment study
In connection with the project: “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded from…
20.06.2022
PRICE INQUIRY No. 5 - being conducted as a market assessment study – extension of the deadline for submitting quotations
In connection with the project titled: “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded…
27.05.2022
REQUEST FOR QUOTATIONS No. 4 - being conducted as a market assessment study
In connection with the project titled: “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded…
22.03.2022
PRICE INQUIRY No. 1 - being conducted as a market assessment study – extension of the deadline for submitting quotations.
In connection with the project titled: “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded…
07.03.2022 News
In solidarity with Ukraine
As Polpharma, we express our solidarity with the Ukrainian nation suffering from the war. First of all, we do what we do best -…
07.03.2022 News
X National Conference EPE awarded in the Events Reviews & 2022 Technology Forecast competition
The conference was appreciated by the event industry, which nominates for the award, and selected among 500 events organized by the world's largest companies.…
Polpharma Group
We are the largest Polish manufacturer of pharmaceuticals and a leader of the…
read more